|
DK3324977T3
(da)
*
|
2015-07-22 |
2022-10-17 |
Enanta Pharm Inc |
Benzodiazepinderivater som rsv-inhibitorer
|
|
EP3402799B1
(en)
|
2016-01-15 |
2022-05-04 |
Enanta Pharmaceuticals, Inc. |
Heterocyclic compounds as rsv inhibitors
|
|
GB201613942D0
(en)
*
|
2016-08-15 |
2016-09-28 |
Univ Of Durham The |
An antimicrobial compound
|
|
CN110809472B
(zh)
|
2017-02-16 |
2023-05-23 |
英安塔制药有限公司 |
用于制备苯二氮䓬衍生物的方法
|
|
WO2018226801A1
(en)
|
2017-06-07 |
2018-12-13 |
Enanta Pharmaceuticals, Inc. |
Aryldiazepine derivatives as rsv inhibitors
|
|
WO2019006291A1
(en)
|
2017-06-30 |
2019-01-03 |
Enanta Pharmaceuticals, Inc. |
HETEROCYCLIC COMPOUNDS AS RSV INHIBITORS
|
|
US11091501B2
(en)
|
2017-06-30 |
2021-08-17 |
Enanta Pharmaceuticals, Inc. |
Heterocyclic compounds as RSV inhibitors
|
|
BR112020006334A2
(pt)
|
2017-09-29 |
2020-09-24 |
Enanta Pharmaceuticals, Inc. |
combinação de agentes farmacêuticos como inibidores de rsv
|
|
US10647711B2
(en)
|
2017-11-13 |
2020-05-12 |
Enanta Pharmaceuticals, Inc. |
Azepin-2-one derivatives as RSV inhibitors
|
|
WO2019199908A1
(en)
|
2018-04-11 |
2019-10-17 |
Enanta Pharmaceuticals, Inc. |
Heterocyclic compounds as rsv inhibitors
|
|
WO2019222538A1
(en)
*
|
2018-05-16 |
2019-11-21 |
The University Of North Carolina At Chapel Hill |
Aminopyrimidines and aminopyridines as mertk inhibitors and their application in cancer treatment
|
|
BR112021018335A2
(pt)
|
2019-03-18 |
2021-11-23 |
Enanta Pharm Inc |
Derivados de benzodiazepina como inibidores de rsv
|
|
WO2020210246A1
(en)
|
2019-04-09 |
2020-10-15 |
Enanta Pharmaceuticals, Inc, |
Heterocyclic compounds as rsv inhibitors
|
|
GB201911944D0
(en)
|
2019-08-20 |
2019-10-02 |
Reviral Ltd |
Pharmaceutical compounds
|
|
AU2020357452B2
(en)
|
2019-10-04 |
2026-01-29 |
Enanta Pharmaceuticals, Inc |
Antiviral heterocyclic compounds
|
|
US11505558B1
(en)
|
2019-10-04 |
2022-11-22 |
Enanta Pharmaceuticals, Inc. |
Antiviral heterocyclic compounds
|
|
GB201915273D0
(en)
|
2019-10-22 |
2019-12-04 |
Reviral Ltd |
Pharmaceutical compounds
|
|
GB201915932D0
(en)
|
2019-11-01 |
2019-12-18 |
Reviral Ltd |
Pharmaceutical compounds
|
|
WO2022010882A1
(en)
|
2020-07-07 |
2022-01-13 |
Enanta Pharmaceuticals, Inc, |
Dihydroquinoxaline and dihydropyridopyrazine derivatives as rsv inhibitors
|
|
GB202010409D0
(en)
|
2020-07-07 |
2020-08-19 |
Reviral Ltd |
Pharmaceutical compounds
|
|
GB202010408D0
(en)
|
2020-07-07 |
2020-08-19 |
Reviral Ltd |
Pharmaceutical compounds
|
|
US11945824B2
(en)
|
2020-10-19 |
2024-04-02 |
Enanta Pharmaceuticals, Inc. |
Heterocyclic compounds as anti-viral agents
|
|
GB202102602D0
(en)
|
2021-02-24 |
2021-04-07 |
Reviral Ltd |
Pharmaceutical compounds
|
|
US12612412B2
(en)
|
2021-02-26 |
2026-04-28 |
Enanta Pharmaceuticals, Inc. |
Antiviral heterocyclic compounds
|
|
AR129003A1
(es)
|
2022-04-07 |
2024-07-03 |
Enanta Pharm Inc |
Compuestos heterocíclicos antivirales
|
|
WO2023211997A1
(en)
|
2022-04-27 |
2023-11-02 |
Enanta Pharmaceuticals, Inc. |
Antiviral compounds
|
|
WO2024252355A1
(en)
|
2023-06-08 |
2024-12-12 |
Pfizer Inc. |
Pediatric dosing regimens comprising a fusion inhibitor for the treatment of rsv
|
|
WO2025120500A1
(en)
|
2023-12-06 |
2025-06-12 |
Pfizer Inc. |
Benzodiazepine compounds as n-protein inhibitors
|
|
WO2025153942A1
(en)
|
2024-01-16 |
2025-07-24 |
Pfizer Inc. |
Benzodiazepine pyrazolo carboxamides as n-protein inhibitors
|